Document:

Exhibit 10.60

 

DEBT PURCHASE AGREEMENT 

 

THIS DEBT
PURCHASE AGREEMENT (this "Agreement"), is made and entered into as of the  15th  day
of July, 2015, by and among TCA GLOBAL CREDIT MASTER FUND, LP, a Cayman Islands limited partnership, with an address of
3960 Howard Hughes Parkway, Suite 500, Las Vegas, NV 89169 ("Assignor" or "Lender"),
REDWOOD MANAGEMENT, LLC, a Florida limited liability company, with an address of 16850 Collins Ave., Suite 112-341, Sunny
Isles, Florida 33160 ("Assignee"), and MYECHECK, INC., a Wyoming corporation (the "Borrower").

 

WITNESSETH

 

WHEREAS,
the Borrower and Lender entered into a Securities Purchase Agreement dated as of August 31, 2014, but made effective as of October
29, 2014 (such Securities Purchase Agreement, together with any other amendments, renewals, substitutions, replacements or modifications
from time to time, collectively referred to as the "Purchase Agreement"); and

 

WHEREAS, pursuant
to the Purchase Agreement, the Borrower executed and delivered to Lender that certain Senior Secured, Convertible, Redeemable Debenture
dated as of August 31, 2014, but made effective as of October 29, 2014 (such Debenture, together with any other amendments, renewals,
substitutions, replacements or modifications from time to time, collectively referred to as the "Debenture");
and

 

WHEREAS,
pursuant to Section 4 (a)(1) of the Securities Act of 1933, as amended (the "Securities Act"), Assignee
desires to purchase from Lender, and Lender is amenable to selling and assigning to Assignee, Assignor's right, title and interest
in and to the monetary obligations evidenced by the Debenture (the "Assigned Debt"), which Assigned Debt
shall be purchased by Assignee in tranches as more specifically hereinafter set forth; and

 

WHEREAS,
on or prior to each "Purchase Tranche Closing" (as hereinafter defined), as directed by Lender, the Borrower agrees to
sever, split, divide and apportion the Debenture, as applicable (or any replacement debentures issued in replacement thereof as
hereby contemplated, as applicable) into two separate and distinct replacement debentures, each in substantially the form as set
forth on Exhibit "A" attached hereto (the "Debenture Form"), one for the amount
of the portion of the Assigned Debt being sold and assigned at such Purchase Tranche Closing (the portion of the Assigned Debt
being sold and assigned at each separate Purchase Tranche Closing, as applicable, being referred to as the "Applicable
Assigned Debt"), and one for the remaining amount of the overall debt evidenced by the Debenture (or any replacement
debentures issued in replacement thereof as hereby contemplated, as applicable);

 

NOW, THEREFORE,
in consideration of the mutual covenants hereinafter set forth, and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged and agreed, Assignor, Assignee, and Borrowers hereby covenant and agree as follows:

 

1.           Recitals.
The recitations set forth in the preamble of this Agreement are true and correct and incorporated herein by this reference.

 

    	1 

     

    

 

2.           Agreement
to Assign Assigned Debt.

 

(a)          Purchase
Tranche Closings. Provided there is no default or breach under this Agreement, and that no event has occurred that, with the
passage of time, the giving of notice, or both, would constitute a default or breach under this Agreement, and subject to all the
terms and provisions of this Agreement, the Assignor hereby agrees to sell and assign to Assignee, and Assignee hereby agrees to
purchase from Assignor, the Assigned Debt, which Assigned Debt shall be sold in four (4) separate tranches (each of such tranches
hereinafter referred to as a "Purchase Tranche"), each of such separate Purchase Tranches to be
sold and assigned on the respective dates and for the respective amounts set forth in the schedule attached hereto as Exhibit
"B" (each closing of a Purchase Tranche referred to as a "Purchase Tranche Closing"
and the purchase price to be paid for each Applicable Assigned Debt at each Purchase Tranche Closing, as shown on such attached
schedule, referred to as the "Applicable Purchase Price"); provided, however, Assignee may
elect to purchase a greater portion of the Assigned Debt than that set forth in the attached schedule for any given Purchase Tranche
Closing, up to the aggregate amount of the Assigned Debt, by written notice to Assignor and Borrower delivered prior to the applicable
Purchase Tranche Closing.

 

(b)          Deliveries
at Each Purchase Tranche Closing. Subject to the terms of this Agreement, at each Purchase Tranche Closing: (i) Lender shall
execute and deliver to Assignee, an assignment of the Applicable Assigned Debt being sold and assigned at such Purchase Tranche
Closing, substantially in the form attached hereto as Exhibit "C" (each, an "Assignment");
(ii) Lender shall deliver to Assignee the original replacement debenture for the Applicable Assigned Debt being sold and assigned
at such Purchase Tranche Closing (subject to receipt of same by Lender from Borrower as provided in Section 2(c) below); and (iii)
Assignee shall pay to Lender the Applicable Purchase Price for the Applicable Assigned Debt being sold and assigned at such Purchase
Tranche Closing, by wire transfer of good and cleared U.S. currency to an account designated by Lender.

 

(c)          Borrower's
Obligation to Sever Debenture. On or prior to each Purchase Tranche Closing, and within no later than three (3) business days
after request therefor is made by Lender to Borrower, the Borrower agrees to sever, split, divide and apportion the Debenture,
as applicable (or any replacement debentures issued in replacement thereof as hereby contemplated, as applicable) into two separate
and distinct and newly issued replacement debentures, each substantially in the Debenture Form. One of such replacement debentures
shall be for a principal amount equal to the Applicable Purchase Price corresponding to the Applicable Assigned Debt for the applicable
Purchase Tranche Closing, and the second replacement debenture shall be for a principal amount equal to the remaining amount of
the overall debt then existing and evidenced by the Debenture (or any replacement debentures issued in replacement thereof as hereby
contemplated, as applicable). In order to clarify the foregoing, as an example, on or prior to the first Purchase Tranche Closing
contemplated hereby, upon request by Lender, the Borrower shall provide to Lender two replacement debentures in replacement of
the Debenture, one for $50,000.00, which is the Applicable Purchase Price for the Applicable Assigned Debt being sold and assigned
at the first Purchase Tranche Closing, and the second for $601,731.84 (as of July 3,2015), which is the amount of the overall debt
evidenced by the Debenture, less the Applicable Purchase Price for the first replacement debenture being sold and assigned at the
first Purchase Tranche Closing. This second replacement debenture shall then be severed in the same manner for the second Purchase
Tranche Closing, and this foregoing process of severing and issuing replacement debentures shall be repeated for each Purchase
Tranche Closing, until the Assigned Debt is sold and assigned in full, or this Agreement is otherwise earlier terminated in accordance
with its terms. Assignee acknowledges and understands that Lender's obligation to sell, assign and deliver each original replacement
debenture representing the Applicable Assigned Debt at each Purchase Tranche Closing is subject to and conditioned upon Borrower
executing and delivering such replacement debentures to Lender in accordance with this Agreement.

 

    	2 

     

    

 

(d)          Remaining
Debt. Assignee and Borrower acknowledge that at each Purchase Tranche Closing, and subject to Lender's receipt of the Applicable
Purchase Price, only the Applicable Assigned Debt represented by the specific replacement debenture representing the applicable
Purchase Tranche shall be deemed sold and assigned hereunder, it being acknowledged by Assignee and by Borrower that the remaining
portion of the debt evidenced by the Debenture (or any replacement debentures issued in replacement thereof as hereby contemplated,
as applicable) for which the Applicable Purchase Price has not been paid and received by Lender (the "Remaining Debt")
shall not be sold or assigned thereby unless and until additional replacement debentures for additional Purchase Tranches are thereafter
sold in accordance with this Agreement and the Applicable Purchase Price therefor is received by Lender.

 

(e)          No Security
Rights. Assignee hereby agrees and acknowledges that the sale, transfer and assignment of the Assigned Debt, or any portion
thereof, shall be a sale, transfer and assignment of the monetary obligations evidenced by such Assigned Debt (or portion thereof)
only, and shall not include, and such sale, transfer and assignment expressly excludes, the Remaining Debt, as well as excluding
any and all security rights, rights to any collateral, or any other security interests or rights of Assignor of any nature or kind
related to, arising under, or pursuant to, the Purchase Agreement, any other "Transaction Documents" (as defined in the
Purchase Agreement) related thereto, or any other security agreements, UCC financing statements, or any other documents or instruments
relating to the obligations of the Borrower, or any "Guarantor" (as defined in the Purchase Agreement) to Assignor (collectively,
the "Security Rights"), it being agreed and acknowledged that all Security Rights shall remain with Assignor,
as security for any portion of the Assigned Debt not assigned at any Purchase Tranche Closing, the Remaining Debt, or any other
obligations of Borrower or any Guarantors to Assignor.

 

3.           Conditions
to Purchases.

 

(a)           Initial Purchase. The initial
Purchase Tranche contemplated hereunder shall be closed and funded simultaneous with the execution of this Agreement by Lender,
Assignee and Borrower.

 

(b)         Additional Purchases. If the first Purchase Tranche Closing is consummated hereunder, and the Applicable Purchase Price
therefor is paid and received by Lender as contemplated under this Agreement, then Assignee's obligation to purchase any additional
Purchase Tranches as hereby contemplated is a binding and continuing obligation of Assignee; provided, however, Assignee shall
have the right to terminate such obligation at any time during the term of this Agreement upon the occurrence of any of the following
events (each a "Trigger Event"): (i) the Borrower fails to stay current in its filing obligations with
the SEC; (ii) trading of the Borrower's Common Stock on the "Principal Trading Market" (as defined in the Purchase Agreement)
is stopped or halted for any reason; (iii) any suspension of electronic trading or settlement services by the Depository Trust
Company ("DTC") with respect to the Common Stock occurs and is continuing, or any receipt by the Borrower
of any notice from DTC to the effect that a suspension of electronic trading or settlement services by DTC with respect to the
Common Stock is being imposed or is contemplated (unless, prior to such suspension, DTC shall have notified the Borrower in writing
that DTC has determined not to impose any such suspension); (iv) the Borrower is in default with its transfer agent (the "Transfer
Agent"), or the Transfer Agent fails to issue to Assignee any shares of the Borrower's Common Stock which may be
due to Assignee in connection with any conversion rights exercised by Assignee under any debentures purchased by Assignee hereunder,
or debentures issued in replacement thereof; (v) the Borrower fails to maintain its active status with the State of Wyoming; (vi)
Borrower shall default (beyond any applicable notice and cure periods) in any of its obligations to Assignee under the debentures
purchased by Assignee hereunder, or debentures issued in replacement thereof, or any other obligations of Borrower to Assignee;
(vii) the average daily dollar volume of the Borrower's Common Stock for the previous twenty (20) trading days is less than $50,000;
or (viii) the Borrower fails to reserve and keep available out of its authorized and unissued shares of Common Stock a number
of shares of Common Stock at least equal to 250% of the number of shares of Common Stock issuable upon conversion of the Assigned
Debt for the sole purpose of issuance upon conversion of the Assigned Debt. Upon the occurrence of a Trigger Event, in the event
Assignee desires to terminate its obligation to purchase Purchase Tranches as hereby contemplated, Assignee shall deliver to Lender
written notice of such termination delivered within five (5) days of the occurrence of the Trigger Event (which notice shall include
a statement of the Trigger Event that has occurred and reasonable evidence of the occurrence thereof), whereupon Assignee's obligation
to purchase any additional Purchase Tranches thereafter shall immediately terminate and be of no further force or effect.

 

    	3 

     

    

 

4.          Representations
and Warranties of Assignor. Assignor makes the following representations and warranties to Assignee, each of which shall be
deemed made as of the Effective Date, and re-made as of each Purchase Tranche Closing:

 

(a)            Assignor is
the legal and equitable owner of Assignor's right, title and interest in and to the Assigned Debt, except for any portion of the
Assigned Debt previously sold and assigned to Assignee pursuant to this Agreement; and

 

(b)         
Assignor has not sold, transferred, assigned, pledged, hypothecated, or otherwise encumbered the Assigned Debt, or any portion
thereof, except for any portion of the Assigned Debt previously sold and assigned to Assignee pursuant to this Agreement; and

 

(c)          The Assignor
is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization with
full right, corporate, partnership or other applicable power and authority to enter into and to consummate the transactions contemplated
by this Agreement and otherwise to carry out its obligations hereunder, and the execution, delivery and performance by the Assignor
of the transactions contemplated by this Agreement have been duly authorized by all necessary corporate, partnership, or similar
action on the part of the Assignor.

 

(d)             The Assignor is not, and for a
period of at least ninety (90) days prior to the date hereof has not been, an "Affiliate" of the Borrower, as said term
is defined in Rule 144 ("Rule 144") of the Rules and Regulations promulgated under the Securities
Act.

 

(e)             This Agreement, when executed and
delivered by the Assignor, will constitute a valid and legally binding obligation of the Assignor, enforceable against the Assignor
in accordance with its terms, except: (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent
conveyance, and any other laws of general application affecting enforcement of creditors' rights generally; or (ii) as limited
by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies.

 

(f)             To the best knowledge of the Assignor,
neither the execution and delivery of this Agreement, or any Assignment, nor the consummation of the transactions contemplated
hereby, does or will violate any constitution, statute, regulation, rule, injunction, judgment, order, decree, ruling, charge
or other restriction of any government, governmental agency, or court to which the Assignor is subject or any provision of its
organizational documents or other similar governing instruments, or conflict with, violate or constitute a default under any agreement,
credit facility, debt or other instrument or understanding to which the Assignor is a party. The Assignor has consulted such legal,
tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with this Agreement
and the assignment of the Assigned Debt, any portion thereof, or any instruments evidencing same as contemplated hereby.

 

(g)             There is no
action, suit, proceeding, judgment, claim or investigation pending, or to the knowledge of the Assignor, threatened against the
Assignor which could reasonably be expected in any manner to challenge or seek to prevent, enjoin, alter or materially delay any
of the transactions contemplated hereby, except that Assignor has filed suit against the Borrower and others seeking repayment
of the sums due under the Purchase Agreement and related Transaction Documents.

 

    	4 

     

    

 

(h)             No authorization,
consent, approval or other order of, or declaration to or filing with, any governmental agency or body or other Person is required
for the valid authorization, execution, delivery and performance by the Assignor of this Agreement and the consummation of the
transactions contemplated hereby, except for authorizations, consents, and approvals obtained prior to the date hereof.

 

(i)              Except for the foregoing representations
and warranties, this Agreement and each Assignment is made by Assignor without recourse, representation or warranty of any nature
or kind, express or implied, and Assignor specifically disclaims any warranty, guaranty or representation, oral or written, past,
present or future with respect to the Assigned Debt, any portion thereof, or any instruments evidencing same, including, without
limitation: (i) the validity, effectiveness or enforceability of the Assigned Debt, any portion thereof, or any instruments evidencing
same; (ii) the validity, existence, or priority of any lien or security interest securing the obligations of Borrower or any other
Credit Parties evidenced by the Assigned Debt, any portion thereof, or any instruments evidencing same; (iii) the existence of,
or basis for, any claim, counterclaim, defense or offset relating to the Assigned Debt, any portion thereof, or any instruments
evidencing same; (iv) the financial condition of the Borrower, or any other Credit Parties or guarantor or obligor liable under
the Assigned Debt, any portion thereof, or any instruments evidencing same, or the ability of any such parties to pay or perform
their respective obligations under the Assigned Debt, any portion thereof, or any instruments evidencing same; (v) the compliance
of the Assigned Debt, any portion thereof, or any instruments evidencing same with any laws, ordinances or regulations of any
governmental agency or other body; (vi) the value or condition of any collateral securing the obligations under the Assigned Debt,
any portion thereof, or any instruments evidencing same; and (vii) the future performance of the Borrower or any other Credit
Parties or guarantor or obligor liable under the Assigned Debt, any portion thereof, or any instruments evidencing same. Assignee
acknowledges and represents to Assignor that Assignee has been given the opportunity to undertake its own investigations of the
Borrower, the Assigned Debt, any portion thereof, or any instruments evidencing same, and having undertaken and performed all
such investigations as Assignee deemed necessary or desirable, Assignee represents, warrants and agrees that it is relying solely
on its own investigation of the Borrower, the Assigned Debt, any portion thereof, or any instruments evidencing same, and not
any information whatsoever provided or to be provided by Assignor, or any representation or warranty of Assignor. This Agreement,
and each Assignment of the Assigned Debt, or portion thereof, as provided for herein is made on an "AS IS,"
"WHERE IS" basis, with all faults, and Assignee, by acceptance of this Agreement and each Assignment,
shall be deemed to have agreed and acknowledged that Assignor has fully performed, discharged and complied with all of Assignor's
obligations, representations, warranties, covenants and agreements hereunder, that Assignor is discharged therefrom, and that
Assignor shall have no further liability with respect thereto, except only for those express warranties contained in this Agreement,
and Assignee, by such acceptance, expressly acknowledges that ASSIGNOR MAKES NO WARRANTY OR REPRESENTATIONS, EXPRESS OR IMPLIED,
OR ARISING BY OPERATION OF LAW, RELATING TO THE ASSIGNED DEBT, ANY PORTION THEREOF, OR ANY INSTRUMENTS EVIDENCING SAME, EXCEPT
AS SPECIFICALLY SET FORTH HEREIN.

 

5.             Representations
and Warranties of Assignee. Assignee makes the following representations and warranties to Assignor, each of which shall be
deemed made as of the Effective Date, and re-made as of each Purchase Tranche Closing:

 

    	5 

     

    

 

(a)             The Assignee
is a legally recognized entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its
organization with full right, corporate, partnership or other applicable power and authority to enter into and to consummate the
transactions contemplated by this Agreement and otherwise to carry out its obligations hereunder, and the execution, delivery and
performance by the Assignee of the transactions contemplated by this Agreement have been duly authorized by all necessary corporate
or similar action on the part of the Assignee.

 

(b)             This Agreement, when executed and
delivered by the Assignee, will constitute a valid and legally binding obligation of the Assignee, enforceable against the Assignee
in accordance with its terms, except: (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent
conveyance, and any other laws of general application affecting enforcement of creditors' rights generally; or (ii) as limited
by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies.

 

(c)             The Assignee:
(i) either alone or together with its representatives, has such knowledge and experience in financial and business matters as to
be capable of evaluating the merits and risks of this investment and make an informed decision to so invest, and has so evaluated
the risks and merits of such investment; (ii) has the ability to bear the economic risks of this investment and can afford a complete
loss of such investment; (iii) understands the terms of and risks associated with the acquisition of the Assigned Debt, or any
portion thereof, or any instruments evidencing same, including, without limitation, a lack of liquidity, price transparency or
pricing availability and risks associated with the industry in which the Borrower operates; (iv) has had the opportunity to review
the Borrowers, its business, its financial condition, its prospects, the Purchase Agreement, the Assigned Debt, any portion thereof,
or any instruments evidencing same, all as the Assignee has determined to be necessary in connection with this Agreement and the
assignments contemplated hereby.

 

(d)
          The Assignee understands that: (i) the Assigned Debt, any portion
thereof, or any instruments evidencing same, have not been registered under the Securities Act or the securities laws of any
state; (ii) the Assigned Debt, any portion thereof, or any instruments evidencing same, is and will be "restricted
securities" as said term is defined in Rule 144; (iii) the Assigned Debt, any portion thereof, or any instruments
evidencing same, may not be sold, pledged or otherwise transferred unless a registration statement for such transaction is
effective under the Securities Act and any applicable state securities laws, or unless an exemption from such registration is
available with respect to such transaction; and (iv) the Assigned Debt, any portion thereof, or any instruments evidencing
same, will contain restrictive legends as to the foregoing in customary form.

 

(e)             The Assignee
is not accepting this Agreement or any Assignment as a result of any advertisement, article, notice or other communication regarding
the Assigned Debt, any portion thereof, or any instruments evidencing same published in any newspaper, magazine, internet or social
media, broadcast over television or radio, presented at any seminary, or under any other media generally circulated or available
to the public or any other general solicitation or general advertisement.

 

(f)          
Neither the execution and delivery of this Agreement, or any Assignment, nor the consummation of the transactions contemplated
hereby, does or will violate any constitution, statute, regulation, rule, injunction, judgment, order, decree, ruling, charge
or other restriction of any government, governmental agency, or court to which the Assignee is subject or any provision of its
organizational documents or other similar governing instruments, or conflict with, violate or constitute a default under any agreement,
credit facility, debt or other instrument or understanding to which the Assignee is a party. The Assignee has consulted such legal,
tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with this Agreement
and the assignment of the Assigned Debt, any portion thereof, or any instruments evidencing same as contemplated hereby.

 

    	6 

     

    

 

(g)             There is no action, suit, proceeding,
judgment, claim or investigation pending, or to the knowledge of the Assignee, threatened against the Assignee which could reasonably
be expected in any manner to challenge or seek to prevent, enjoin, alter or materially delay any of the transactions contemplated
hereby.

 

(h)             No authorization, consent, approval
or other order of, or declaration to or filing with, any governmental agency or body or other Person is required for the valid
authorization, execution, delivery and performance by the Assignee of this Agreement and the consummation of the transactions contemplated
hereby.

 

(i)          The Assignee hereby acknowledges
that the Assigned Debt, any portion thereof, or any instruments evidencing same may only be disposed of in compliance with state
and federal securities laws. The Assignee further acknowledges that in connection with any transfer of the Assigned Debt, any portion
thereof, or any instruments evidencing same subsequent to the date hereof and other than pursuant to an effective registration
statement, or an applicable exemption to such registration requirements, the Borrower and/or the Borrower's transfer agent may
require an opinion of counsel, the form and substance of which opinion shall be reasonably satisfactory to the Borrower and/or
the Borrower's transfer agent, as applicable.

 

6.         
Borrower Acknowledgments.         Borrower hereby represents and warrants
that the obligations evidenced by the Debenture, including, without limitation, all obligations for the Assigned Debt, are valid
and enforceable obligations of the Borrower subject to no defenses, setoffs, counterclaims, cross-actions or equities in favor
of the Borrower, and to the extent the Borrower has any defenses, setoffs, counterclaims, cross-actions or equities against Assignor
and/or against the enforceability of any such obligations, the Borrower acknowledges and agrees that same are hereby fully and
unconditionally waived by the Borrower. The Borrower further acknowledges its obligations under Section 2(c) above, and agrees
to timely and promptly deliver replacement debentures to Lender as required by this Agreement. The Borrower further acknowledges
that the Assigned Debt is only being assigned hereunder in Purchase Tranches as contemplated above. In that regard, the Borrower
further acknowledges that the Remaining Debt is and remains valid and enforceable obligations of the Borrower. Borrower agrees
and acknowledges that it is and shall remain liable to pay the Remaining Debt, as same becomes due in accordance with the terms
of the Purchase Agreement and the Debenture, or any replacement debentures issued in replacement thereof as hereby contemplated,
and nothing contained herein shall be deemed or construed as any waiver or to otherwise excuse performance by Borrower under their
obligations to Lender.

 

7.             RELEASE.
AS A MATERIAL INDUCEMENT FOR LENDER TO AGREE TO ENTER INTO THIS AGREEMENT, BORROWER AND ASSIGNEE HEREBY RELEASE LENDER, TOGETHER
WITH ALL OF ITS PARTNERS AND AFFILIATES, AND THE OFFICERS, MEMBERS, DIRECTORS, PARTNERS, EMPLOYEES, AGENTS AND ATTORNEYS OF EACH
OF THE FOREGOING, FROM ALL CLAIMS, CAUSES OF ACTION AND LIABILITIES OF ANY NATURE OR KIND IN ANY WAY RELATING, DIRECTLY OR INDIRECTLY,
TO THE ASSIGNED DEBT, ANY COLLATERAL SECURING ANY OBLIGATIONS THEREUNDER, THIS AGREEMENT, OR ANY OTHER DEBTS OR OBLIGATIONS IN
ANY WAY RELATING TO THE PURCHASE AGREEMENT, TO THE EXTENT ARISING ON OR PRIOR TO THE DATE HEREOF, INCLUDING, WITHOUT LIMITATION,
ANY AND ALL CLAIMS ARISING FROM OR RELATING TO NEGOTIATIONS, DEMANDS, REQUESTS OR EXERCISE OF REMEDIES IN CONNECTION WITH THE ASSIGNED
DEBT, THIS AGREEMENT, ANY OTHER DEBTS OR OBLIGATIONS IN ANY WAY RELATING TO THE PURCHASE AGREEMENT, AND ANY AND ALL FEES OR CHARGES
COLLECTED IN CONNECTION WITH THE ASSIGNED DEBT, THIS AGREEMENT, OR ANY OTHER DEBTS OR OBLIGATIONS IN ANY WAY RELATING TO THE PURCHASE
AGREEMENT. MOREOVER UPON DELIVERY OF EACH ASSIGNMENT HEREUNDER, THE FOREGOING RELEASE SHALL BE DEEMED AUTOMATICALLY RE-MADE AND
EFFECTIVE FOR ALL CLAIMS, CAUSES OF ACTION AND LIABILITIES OF ANY NATURE OR KIND COVERED HEREBY TO THE EXTENT ARISING ON OR PRIOR
TO THE DATE OF SUCH ASSIGNMENT.

 

    	7 

     

    

 

8.          Default
and Termination.

 

(a)         
Breach By Assignor. In the event Assignor shall breach any of its covenants or agreements hereunder, and such breach
is not cured within twenty (20) days after Assignor's receipt of written notice of such breach from Assignee, which notice shall
specify the breach with specificity, then Assignee's sole and exclusive remedy hereunder shall be to terminate this Agreement
upon written notice to Assignor, whereupon this Agreement shall terminate and Assignor and Assignee shall have no further obligation,
each to the other, under this Agreement. Assignor and Assignee agree that the foregoing exclusive remedy will be adequate and
each of them agrees that Assignee shall not have any other remedies, at law or in equity, for any breach by Assignor not cured
within any applicable notice and cure period, other than termination of this Agreement as hereby provided.

 

(b)           Breach By Assignee. In the
event Assignee shall breach any of its covenants or agreements hereunder, and such breach is not cured within twenty (20) days
after Assignee's receipt of written notice of such breach from Assignor, which notice shall specify the breach with specificity,
then Assignor's sole and exclusive remedy hereunder shall be to terminate this Agreement upon written notice to Assignee, whereupon
this Agreement shall terminate and Assignor and Assignee shall have no further obligation, each to the other, under this Agreement.
Assignor and Assignee agree that the foregoing exclusive remedy will be adequate and each of them agrees that Assignor shall not
have any other remedies, at law or in equity, for any breach by Assignee not cured within any applicable notice and cure period,
other than termination of this Agreement as hereby provided. Notwithstanding the foregoing to the contrary, the foregoing notice
and cure period shall not be applicable with respect to Assignee's failure to pay the Applicable Purchase Price at a Purchase
Tranche Closing, and any such failure shall be deemed an immediate breach hereunder, entitling Assignor to avail itself of the
exclusive termination remedy hereby provided immediately upon such failure to pay the Applicable Purchase Price at a Purchase
Tranche Closing.

 

(c)             Breach by Borrower. Any breach
by Borrower under this Agreement shall be deemed an event of default by Borrower under the Purchase Agreement, and any such breach
may be enforced by Assignor through any remedies available to Assignor, at law or in equity, or under the Purchase Agreement. Borrower
shall have no rights to enforce this Agreement as against Assignor or Assignee, nor shall any breach or default by Assignor or
Assignee hereunder in any way abrogate, limit, or otherwise affect Borrower's obligations under the Purchase Agreement and related
Loan Documents.

 

9.             No Waiver.
The parties recognize and acknowledge that by entering into this Agreement, the Lender is not waiving any rights or remedies it
may have under the Purchase Agreement or any of the Transaction Documents, any defaults or Events of Default arising thereunder,
or any judgments previously obtained by Lender in connection therewith, if any. In addition, notwithstanding anything contained
in this Agreement to the contrary, the Lender shall have the right, at any time, to accept payment in full of the then outstanding
Remaining Debt (from Borrower, Assignee, or any other Person), and in such event, Lender shall have the absolute right to terminate
this Agreement, without liability to Assignee or any other Person, with respect to any portion of the Assigned Debt not yet sold
and assigned to Assignee as of such date.

 

10.         Governing
Law. This Agreement shall be governed by and construed in accordance with the laws governing the Debenture.

 

    	8 

     

    

 

11.           Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors
and assigns.

 

12.           Headings.
The headings of the paragraphs of this Agreement have been included only for convenience, and shall not be deemed in any manner
to modify or limit any of the provisions of this Agreement or used in any manner in the interpretation of this Agreement.

 

13.         Interpretation.
Whenever the context so requires in this Agreement, all words used in the singular shall be construed to have been used in the
plural (and vice versa), each gender shall be construed to include any other genders, and the word "Person"
shall be construed to include a natural person, a corporation, a firm, a partnership, a joint venture, a trust, an estate or
any other entity.

 

14.           Partial
Invalidity. Each provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law. If any
provision of this Agreement or the application of such provision to any person or circumstances shall, to any extent, be invalid
or unenforceable, then the remainder of this Agreement, or the application of such provision to persons or circumstances other
than those as to which it is held invalid or unenforceable, shall not be affected by such invalidity or unenforceability.

 

15.         Execution.
This Agreement may be executed in one or more counterparts, all of which taken together shall be deemed and considered one and
the same Agreement, and same shall become effective when counterparts have been signed by each party and each party has delivered
its signed counterpart to the other party. In the event that any signature is delivered by facsimile transmission or by e-mail
delivery of a ".pdf' format file or other similar format file, such signature shall be deemed an original for all purposes
and shall create a valid and binding obligation of the party executing same with the same force and effect as if such facsimile
or ".pdf" signature page was an original thereof.

 

16.        Effective
Date. For purposes of this Agreement, the "Effective Date" shall mean the date when this Agreement
becomes fully executed by all parties hereto.

 

[Signatures on the following page]

 

    	9 

     

    

 

IN WITNESS
WHEREOF, Assignor. Assignee. and Borrower have executed this Agreement as of the date above first written.

 

	 	Assignor:
	 	 
	 	TCA GLOBAL CREDIT MASTER FUND, LP
	 	 	 
	 	By:	TCA Global Credit Fund GP. Ltd.
	 	Its:	General Partner
	 	 	 
	 	By:	/s/ Robert Press
	 	 	Robert Press, Director
	 	 	 
	 	Date:	15-July, 2015
	 	 	 
	 	Assignee:
	 	 
	 	REDWOOD MANAGEMENT, LLC. a Florida limited liability company
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 
	 	 	 
	 	Date:	 

 

    	10 

     

    

 

IN WITNESS
WHEREOF. Assignor. Assignee. and Borrower have executed this Agreement as of the date above first written.

 

	 	Assignor:
	 	 
	 	TCA GLOBAL CREDIT MASTER FUND, LP
	 	 	 
	 	By:	TCA Global Credit Fund GP, Ltd.
	 	Its:	General Partner
	 	 	 
	 	By:	 
	 	 	Robert Press, Director
	 	 	 
	 	Date:	 
	 	 	 
	 	Assignee:
	 	 
	 	REDWOOD MANAGEMENT, LLC. a Florida limited liability company
	 	 	 
	 	By:	/s/ John DeNobile
	 	Name:	John DeNobile
	 	Title:	Manager
	 	 	 
	 	Date:	7/15/15

 

    	11 

     

    

 

IN WITNESS
WHEREOF. Assignor. Assignee. and Borrower have executed this Agreement as of the date above first written.

 

	Borrower:	 
	 	 
	MYECHECK, INC.. a Wyoming corporation	 
	 	 
	By:	/s/ Ed Starrs	 	 
	Name:	Ed Starrs	 	 
	Title:	CEO	 	 
	Date:	7-14-2015	 	 

 

    	12 

     

    

 

EXHIBIT "A" 

 

FORM DEBENTURE 

 

    	13 

     

    

 

EXHIBIT "B" 

 

PURCHASE TRANCHES 

  

	Purchase
    Tranche Number	 	Available
    Purchase Price	 	 	Date
    for Purchase Tranche 

Closing
	1	 	$	50,000	 	 	On the Effective Date
	2	 	$	200,000	 	 	90 days after Company becomes a full reporting Company with the SEC
	3	 	$	200,000	 	 	120 days after Company becomes a full reporting Company with the SEC
	4	 	$	250,000	 	 	150 days after Company becomes a full reporting Company with the SEC

 

    	14 

     

    

 

EXHIBIT "C" 

 

FORM OF ASSIGNMENT 

 

    	15Exhibit 10.61

 

EXCHANGE AGREEMENT

 

THIS EXCHANGE AGREEMENT
(the “Agreement”) is dated this 16th  day of July, 2015 (the “Effective Date”), by and
among MyECheck, Inc. (the “Company”), and Redwood Management, LLC (the “Holder”).

 

WHEREAS, the Holder
beneficially owns and holds certain Senior Secured Convertible Redeemable Debentures issued by the Company as set forth on Exhibit
A hereto (the “Securities”); and

 

WHEREAS, the Holder
desires to exchange the Securities for the securities of the Company as set forth on Exhibit B (the “Exchange Securities”),
and the Company desires to issue the Exchange Securities in exchange for the Securities, all on the terms and conditions set forth
in this Agreement; and

 

WHEREAS, the reliance
upon the representations made by each of the Holder and the Company in this Agreement, the transactions contemplated by this Agreement
are such that the offer and exchange of securities by the Company under this Agreement will be exempt from registration under applicable
United States securities laws as a result of this exchange offer being undertaken pursuant to Section 4(a)(2) of the Securities
Act of 1933, as amended (the “Securities Act”).

 

NOW, THEREFORE, in
consideration of the terms and conditions contained herein, and other good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, the Company and the Holder hereby agree as follows:

 

Section 1. Exchange.
Subject to and upon the terms and conditions set forth in this Agreement, the Holder agrees to surrender to the Company the Securities
and, in exchange therefore, the Company shall issue to the Holder the Exchange Securities (each, an “Exchange”).

 

1.1 Closing.
On each Closing Date (as defined below), the Company will issue and deliver (or cause to be issued and delivered) the amount of
Exchange Securities set forth on Schedule 1 hereto to the Holder, or in the name of a custodian or nominee of the Holder,
or as otherwise requested by the Holder in writing, and the Holder will surrender to the Company an equal amount of the Securities.
The closing of each Exchange shall occur on the dates set forth on Schedule 1 hereto to, or as soon thereafter as the parties
may mutually agree in writing (each, a “Closing Date”), subject to the provisions of Section 4 and Section
5 herein.

 

1.2 Section
4(a)(2). Assuming the accuracy of the representations and warranties of each of the Company and the Holder set forth in Sections
2 and 3 of this Agreement, the parties acknowledge and agree that the purpose of such representations and warranties is, among
other things, to ensure that the Exchange qualifies as an exchange of securities under Section 4(a)(2) of the Securities Act.

 

    	1 

     

    

 

Section 2. Representations
and Warranties of the Company. The Company represents and warrants to the Holder that:

 

2.1 Organization
and Qualification. The Company and each of the subsidiaries of the Company (the “Subsidiaries”) is an entity duly
incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation
or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as
currently conducted. Neither the Company, nor any Subsidiary is in violation or default of any of the provisions of its respective
certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries
is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in
which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure
to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material
adverse effect on the legality, validity or enforceability of this Agreement or any documents executed in connection herewith (the
“Transaction Documents”), (ii) a material adverse effect on the results of operations, assets, business, prospects
or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect
on the Company’s ability to perform in any material respect on a timely basis its obligations under any Transaction Document
(any of (i), (ii) or (iii), a “Material Adverse Effect”) and no proceeding has been instituted in any such jurisdiction
revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.

 

2.2 Authorization;
Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by
it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company
and no further action is required by the Company, the Board of Directors or the Company’s stockholders in connection herewith
or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which
it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the
terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance
with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.

 

    	2 

     

    

 

2.3 Issuance
of Exchange Securities. The issuance of the Exchange Securities is duly authorized and, upon issuance in accordance with the
terms hereof, the shares of common stock of the Company (the “Underlying Shares”) issuable upon conversion of the Exchange
Securities shall be validly issued, fully paid and non-assessable shares of the Common Stock of the Company. Assuming the truth
and accuracy of each of the representations and warranties of the Holder contained in Section 3 of this Agreement, the issuance
by the Company of the Exchange Securities is exempt from registration under the Securities Act.

 

2.4 No
Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance of the Exchange Securities and the consummation by it of the transactions contemplated hereby
and thereby do not and will not: (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate
or articles of incorporation, bylaws or other organizational or charter documents, (ii) conflict with, or constitute a default
(or an event that with notice or lapse of time or both would become a default) under, result in the creation of any options, contracts,
agreements, liens, security interests, or other encumbrances (“Liens”) upon any of the properties or assets of the
Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or without
notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary
debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of
the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation
of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to
which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property
or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could
not have or reasonably be expected to result in a Material Adverse Effect.

 

2.5 Acknowledgment
Regarding the Exchange. The Company acknowledges and agrees that the Holder are acting solely in the capacity of an arm’s
length third party with respect to this Agreement and the transactions contemplated hereby. The Company further acknowledges the
Holder are not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to this Agreement
and the transactions contemplated hereby, and any advice given by the Holder or any of their representatives or agents in connection
with this Agreement is merely incidental to the Exchange.

 

    	3 

     

    

 

2.6 SEC
Reports; Financial Statements.  The Company has filed all reports, schedules, forms, statements and other documents
required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d)
of the Exchange Act, for the two years preceding the date hereof (or such shorter period as the Company was required by law or
regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference
therein, being collectively referred to herein as the “SEC Reports”) on a timely basis or has received a valid extension
of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension.  As of their
respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange
Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state
a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading.  The financial statements of the Company included in the SEC Reports comply
in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto
as in effect at the time of filing.  Such financial statements have been prepared in accordance with United States generally
accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”), except as may be
otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain
all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated
Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject,
in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.

 

2.7 Subsidiaries.  All
of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports.  The Company owns, directly
or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the
issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free
of preemptive and similar rights to subscribe for or purchase securities.  If the Company has no subsidiaries, all other
references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

 

2.8 Filings,
Consents and Approvals.  The Company is not required to obtain any consent, waiver, authorization or order of, give
any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority
or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than:
(i) the notice and/or application(s) to each applicable Trading Market for the issuance and the listing of the Exchange Securities
for trading thereon in the time and manner required thereby, and (ii) the filing of Form D with the Commission and such filings
as are required to be made under applicable state securities laws (collectively, the “Required Approvals”).

 

    	4 

     

    

 

2.9 Capitalization.  The
capitalization of the Company is as set forth in the SEC Reports.  No Person has any right of first refusal, preemptive
right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents.  There
are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to,
or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe
for or acquire any shares of Common Stock, or contracts, commitments, understandings or arrangements by which the Company or any
Subsidiary is or may become bound to issue additional shares of Common Stock or securities entitling the holder thereof to acquire
shares of Common Stock (“Common Stock Equivalents”). The issuance of the Exchange Securities will not obligate the
Company to issue shares of Common Stock or other securities to any Person (other than the Holder) and will not result in a right
of any holder of Company securities to adjust the exercise, conversion, exchange or reset price under any of such securities. All
of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have
been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation
of any preemptive rights or similar rights to subscribe for or purchase securities.  No further approval or authorization
of any stockholder, the Board of Directors or others is required for the issuance of the Exchange Securities.  There
are no stockholders agreements or other similar agreements with respect to the Company’s capital stock to which the Company
is a party or, to the knowledge of the Company, between or among any of the Company’s stockholders.

 

2.10 Shell
Company Status. The Company is not currently an issuer identified in Rule 144(i)(1) under the Securities Act. 

 

2.11 DTC
Eligibility. The Company, through the Transfer Agent, currently participates in the DTC Fast Automated Securities Transfer
(FAST) Program and the Common Stock can be transferred electronically to third parties via the DTC Fast Automated Securities Transfer
(FAST) Program. 

 

2.12 Material
Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest audited financial statements included
within the SEC Reports, except as specifically disclosed in a subsequent SEC Report filed prior to the date hereof: (i) there has
been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect,
(ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses
incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the
Company’s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not
altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property
to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v)
the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock
option plans. The Company does not have pending before the Commission any request for confidential treatment of information. Except
for the issuance of the Exchange Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence
or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries
or their respective businesses, properties, operations, assets or financial condition, that would be required to be disclosed by
the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly
disclosed at least 1 Trading Day prior to the date that this representation is made.

 

    	5 

     

    

 

2.13 Litigation.  There
is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened
against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental
or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an “Action”)
which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Exchange
Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse
Effect.  Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any
Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary
duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission
involving the Company or any current or former director or officer of the Company.  The Commission has not issued any
stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under
the Exchange Act or the Securities Act.

 

2.14 Labor
Relations.  No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which could reasonably be expected to result in a Material Adverse Effect.  None of the Company’s
or its Subsidiaries’ employees is a member of a union that relates to such employee’s relationship with the Company
or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the
Company and its Subsidiaries believe that their relationships with their employees are good.  To the knowledge of the
Company, no executive officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term
of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any
other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such
executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing
matters.  The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and
regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where
the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.

 

    	6 

     

    

 

2.15 Compliance. Neither
the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived
that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company
or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or
credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether
or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator
or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection,
occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not have
or reasonably be expected to result in a Material Adverse Effect.

 

2.16 Regulatory
Permits. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports,
except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (“Material
Permits”), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or
modification of any Material Permit.

 

2.17 Title
to Assets.  The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned
by them and good and marketable title in all personal property owned by them that is material to the business of the Company and
the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such
property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries
and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance
with GAAP and, the payment of which is neither delinquent nor subject to penalties.  Any real property and facilities
held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which
the Company and the Subsidiaries are in compliance.

 

    	7 

     

    

 

2.18 Intellectual
Property.  The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property
rights and similar rights as described in the SEC Reports as necessary or required for use in connection with their respective
businesses and which the failure to so have could have a Material Adverse Effect (collectively, the “Intellectual Property
Rights”).  None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that
any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be
abandoned, within two (2) years from the date of this Agreement.  Neither the Company nor any Subsidiary has received,
since the date of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise
has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not
have or reasonably be expected to not have a Material Adverse Effect.  To the knowledge of the Company, all such Intellectual
Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights.  The
Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of
their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect.

 

2.19 Insurance. The
Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in
such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but
not limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount.  Neither
the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and
when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without
a significant increase in cost.

 

2.20 Transactions
With Affiliates and Employees.  Except as set forth in the SEC Reports, none of the officers or directors of the
Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently
a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including
any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or
personal property to or from providing for the borrowing of money from or lending of money to, or otherwise requiring payments
to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director,
or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case
in excess of $120,000 other than for: (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses
incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan
of the Company.

 

    	8 

     

    

 

2.21 Sarbanes-Oxley;
Internal Accounting Controls.  The Company and the Subsidiaries are in compliance with any and all applicable requirements
of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated
by the Commission thereunder that are effective as of the date hereof and as of the Closing Date.  The Company and the
Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions
are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary
to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets
is permitted only in accordance with management’s general or specific authorization, and (iv) the recorded accountability
for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information
required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized
and reported, within the time periods specified in the Commission’s rules and forms.  The Company’s certifying
officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the
end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the “ Evaluation
Date ”).  The Company presented in its most recently filed periodic report under the Exchange Act the conclusions
of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the
Evaluation Date.  Since the Evaluation Date, there have been no changes in the internal control over financial reporting
(as such term is defined in the Exchange Act) that have materially affected, or is reasonably likely to materially affect, the
internal control over financial reporting of the Company and its Subsidiaries.

 

2.22 Certain
Fees. No brokerage or finder’s fees or commissions are or will be payable by the Company or any Subsidiaries to any broker,
financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions
contemplated by the Transaction Documents.

 

2.23 Investment
Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Exchange Securities,
will not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940,
as amended.  The Company shall conduct its business in a manner so that it will not become an “investment company”
subject to registration under the Investment Company Act of 1940, as amended.

 

2.24 Registration
Rights. Other than as disclosed in the SEC Reports, no Person has any right to cause the Company to effect the registration
under the Securities Act of any securities of the Company or any Subsidiaries.

 

    	9 

     

    

 

2.25 Listing
and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the
Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration.  Except as set forth in the SEC Reports, the Company has not, in the 12 months preceding the date
hereof, received notice from OTCQB any other exchange or quotation service on which the Company’s securities are traded (the
“Trading Market”) on which the Common Stock is or has been listed or quoted to the effect that the Company is not in
compliance with the listing or maintenance requirements of such Trading Market. Except as set forth in the SEC Reports, the Company
is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing
and maintenance requirements.

 

2.26 Application
of Takeover Protections.  The Company and the Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights
agreement) or other similar anti-takeover provision under the Company’s certificate of incorporation (or similar charter
documents) or the laws of its state of incorporation that is or could become applicable to the Holder as a result of the Holder
and the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation
as a result of the Company’s issuance of the Exchange Securities pursuant to the Exchange.

 

2.27 Disclosure.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company
confirms that neither it nor any other Person acting on its behalf has provided the Holder or its agents or counsel with any information
that it believes constitutes or might constitute material, non-public information. The Company understands and confirms that the
Holder will rely on the foregoing representation in effecting transactions in securities of the Company.  All of the
disclosure furnished by or on behalf of the Company to the Holder regarding the Company and its Subsidiaries, their respective
businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct
and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements made therein, in light of the circumstances under which they were made, not misleading. The press releases disseminated
by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made and when made, not misleading. The Company acknowledges and agrees
that the Holder makes no nor has made any representations or warranties with respect to the transactions contemplated hereby other
than those specifically set forth in Section 3 hereof.

 

    	10 

     

    

 

2.28 No
Integrated Offering. Assuming the accuracy of the Holder’s representations and warranties set forth in Section 3, neither
the Company, nor any of its Affiliates, nor any Person acting on their behalf has, directly or indirectly, made any offers or sales
of any security or solicited any offers to buy any security, under circumstances that would cause the Exchange to be integrated
with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of any such securities
under the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of the securities
of the Company are listed or designated.

 

2.29 Solvency.
The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing
and amounts of cash to be payable on or in respect of its debt).  Except as set forth in the SEC Reports, the Company
has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under
the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date. The SEC Reports set forth as of
the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or
any Subsidiary has commitments.  For the purposes of this Agreement, “Indebtedness” means (x) any liabilities
for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary course of business),
(y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same,
are, or should be, reflected in the Company’s consolidated balance sheet (or the notes thereto), except guaranties by endorsement
of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z) the present
value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP. Except as
set forth in the SEC Reports, neither the Company nor any Subsidiary is in default with respect to any Indebtedness.

 

2.30 Tax
Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local
income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject,
(ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due
on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of
all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid
taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or
of any Subsidiary know of no basis for any such claim.

 

    	11 

     

    

 

2.31 Foreign
Corrupt Practices. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent
or other person acting on behalf of the Company or any Subsidiary, has: (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any
unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns
from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person
acting on its behalf of which the Company is aware) which is  in violation of law or (iv) violated in any material respect
any provision of FCPA.

 

2.32 No
Disagreements with Accountants and Lawyers. There are no disagreements of any kind presently existing, or reasonably anticipated
by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and
the Company is current with respect to any fees owed to its accountants and lawyers which could affect the Company’s ability
to perform any of its obligations under any of the Transaction Documents.

 

2.33 Acknowledgment
Regarding Holder’s Exchange of Securities. The Company acknowledges and agrees that the Holder are acting solely in the
capacity of an arm’s length party with respect to the Transaction Documents and the transactions contemplated thereby.

 

2.34 
Regulation M Compliance. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or
indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the
Company to facilitate the issuance or resale of any of the Exchange Securities, (ii) sold, bid for, purchased, or paid any compensation
for soliciting purchases of, any of the Exchange Securities, or (iii) paid or agreed to pay to any Person any compensation for
soliciting another to purchase any other securities of the Company.

 

2.35 Office
of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company's knowledge, any director, officer, agent,
employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of
Foreign Assets Control of the U.S. Treasury Department (“OFAC”).

 

2.36 Bank
Holding Company Act.  Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding
Company Act of 1956, as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve System
(the “Federal Reserve”).  Neither the Company nor any of its Subsidiaries or Affiliates owns or controls,
directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent
or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.  Neither
the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank
or any entity that is subject to the BHCA and to regulation by the Federal Reserve.

 

    	12 

     

    

 

2.37 Money
Laundering.  The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance
with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970,
as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the “Money
Laundering Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority or body or
any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge
of the Company or any Subsidiary, threatened.

 

Section 3. Representations
and Warranties of the Holder. Each Holder represents and warrants, severally and not jointly, to the Company that:

 

3.1 Ownership
of the Securities. The Holder is the legal and beneficial owner of the Securities. The Holder paid for the Securities, and
has continuously held the Securities since its issuance or purchase. The Holder, individually or through an affiliate, owns the
Securities outright and free and clear of any options, contracts, agreements, liens, security interests, or other encumbrances.

 

3.2 No
Public Sale or Distribution. The Holder is acquiring the Exchange Securities in the ordinary course of business for its own
account and not with a view toward, or for resale in connection with, the public sale or distribution thereof; provided, however,
that by making the representations herein, the Holder does not agree to hold any of the Exchange Securities for any minimum or
other specific term and reserves the right to dispose of the Exchange Securities at any time in accordance with an exemption from
the registration requirements of the Securities Act and applicable state securities laws. The Holder does not presently have any
agreement or understanding, directly or indirectly, with any person to distribute, or transfer any interest or grant participation
rights in, the Securities or the Exchange Securities.

 

3.3 Accredited
Investor and Affiliate Status. The Holder is an “accredited investor” as that term is defined in Rule 501 of Regulation
D under the Securities Act. The Holder is not, and has not been, for a period of at least three months prior to the date of this
Agreement (a) an officer or director of the Company, (b) an “affiliate” of the Company (as defined in Rule 144) (an
“Affiliate”) or (c) a “beneficial owner” of more than 10% of the common stock (as defined for purposes
of Rule 13d-3 of the Exchange Act).

 

3.4 Reliance
on Exemptions. The Holder understands that the Exchange is being made in reliance on specific exemptions from the registration
requirements of United States federal and state securities laws and that the Company is relying in part upon the truth and accuracy
of, and each Holder’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of
the Holder set forth herein in order to determine the availability of such exemptions and the eligibility of each Holder to complete
the Exchange and to acquire the Exchange Securities.

 

    	13 

     

    

 

3.5 Information.
The Holder has been furnished with all materials relating to the business, finances and operations of the Company and materials
relating to the Exchange which have been requested by the Holder. The Holder has been afforded the opportunity to ask questions
of the Company. Neither such inquiries nor any other due diligence investigations conducted by the Holder or its representatives
shall modify, amend or affect the Holder’s right to rely on the Company’s representations and warranties contained
herein. The Holder acknowledges that all of the documents filed by the Company with the SEC under Sections 13(a), 14(a) or 15(d)
of the Exchange Act that have been posted on the SEC’s EDGAR site are available to the Holder, and the Holder has not relied
on any statement of the Company not contained in such documents in connection with the Holder’s decision to enter into this
Agreement and the Exchange.

 

3.6 Risk.
The Holder understands that its investment in the Exchange Securities involves a high degree of risk. The Holder is able to bear
the risk of an investment in the Exchange Securities including, without limitation, the risk of total loss of its investment. The
Holder has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision
with respect to the Exchange. There is no assurance that the Exchange Securities will continue to be quoted, traded or listed for
trading or quotation on the Nasdaq Capital Market or on any other organized market or quotation system.

 

3.7 No
Governmental Review. The Holder understands that no United States federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement in connection with the Exchange or the fairness or suitability of
the investment in the Exchange Securities nor have such authorities passed upon or endorsed the merits of the Exchange Securities.

 

3.8 Organization;
Authorization. The Holder is duly organized, validly existing and in good standing under the laws of its state of formation
and has the requisite organizational power and authority to enter into and perform its obligations under this Agreement.

 

3.9 Validity;
Enforcement. This Agreement has been duly and validly authorized, executed and delivered on behalf of the Holder and shall
constitute the legal, valid and binding obligations of the Holder enforceable against the Holder in accordance with its terms.
The execution, delivery and performance of this Agreement by the Holder and the consummation by the Holder of the transactions
contemplated hereby (including, without limitation, the irrevocable surrender of the Securities) will not result in a violation
of the organizational documents of the Holder.

 

    	14 

     

    

 

3.10 Prior
Investment Experience. The Holder acknowledges that it has prior investment experience, including investment in securities
of the type being exchange, including the Securities or the Exchange Securities, and has read all of the documents furnished or
made available by the Company to it and is able to evaluate the merits and risks of such an investment on its behalf, and that
it recognizes the highly speculative nature of this investment.

 

3.11 Tax
Consequences. The Holder acknowledges that the Company has made no representation regarding the potential or actual tax consequences
for the Holder which will result from entering into the Agreement and from consummation of the Exchange. The Holder acknowledges
that it bears complete responsibility for obtaining adequate tax advice regarding the Agreement and the Exchange.

 

3.12 No
Registration, Review or Approval. The Holder acknowledges, understands and agrees that the Exchange Securities are being exchanged
hereunder pursuant to an exchange offer exemption under Section 4(a)(2) of the Securities Act.

 

Section 4. Conditions
Precedent to Obligations of the Company. The obligation of the Company to consummate the transactions contemplated by this
Agreement is subject to the satisfaction on each Closing Date of each of the following conditions, provided that these conditions
are for the Company’s sole benefit and may be waived by the Company at any time in its sole discretion by providing the Holder
with prior written notice thereof:

 

4.1 Delivery.
The Holder shall have delivered to the Company the Securities.

 

4.2 No
Prohibition. No order of any court, arbitrator, or governmental or regulatory authority shall be in effect which purports to
enjoin or restrain any of the transactions contemplated by this Agreement.

 

4.3 Representations.
The accuracy in all material respects when made and on the applicable Closing Date of the representations and warranties of the
Holder contained herein (unless as of a specific date therein).

 

Section 5. Conditions
Precedent to Obligations of the Holder. The obligation of each Holder to consummate the transactions contemplated by this Agreement
is subject to the satisfaction on each Closing Date of each of the following conditions, provided that these conditions are for
each Holder’s sole benefit and may be waived by the applicable Holder at any time in its sole discretion by providing the
Company with prior written notice thereof:

 

5.1 No order
of any court, arbitrator, or governmental or regulatory authority shall be in effect which purports to enjoin or restrain any of
the transactions contemplated by this Agreement;

 

    	15 

     

    

 

5.2 the accuracy
in all material respects when made and on the applicable Closing Date of the representations and warranties of the Company contained
herein (unless as of a specific date therein);

 

5.3 all obligations,
covenants and agreements of the Company required to be performed at or prior to the applicable Closing Date shall have been performed;

 

5.4 there
is no event of default then existing on any Exchange Securities and the Equity Conditions (as defined in the Exchange Securities)
are satisfied on such date; and

 

5.5 from
the date hereof to the relevant Closing Date, trading in the Company’s common stock shall not have been suspended by the
SEC or any trading market and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg
L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are
reported by such service, or on any trading market, nor shall a banking moratorium have been declared either by the United States
or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national
or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in
each case, in the reasonable judgment of the Holder makes it impracticable or inadvisable to purchase the Exchange Securities at
the closing.

 

Section 6. Governing
Law; Jurisdiction; Waiver of Jury Trial. This Agreement shall be construed under the laws of the state of New York, without
regard to principles of conflicts of law or choice of law that would permit or require the application of the laws of another jurisdiction.
The Company and the Holder each hereby agrees that all actions or proceedings arising directly or indirectly from or in connection
with this Agreement shall be litigated only in the Supreme Court of the State of New York or the United States District Court for
the Southern District of New York located in New York County, New York. The Company and the Holder each consents to the exclusive
jurisdiction and venue of the foregoing courts and consents that any process or notice of motion or other application to either
of said courts or a judge thereof may be served inside or outside the State of New York or the Southern District of New York by
generally recognized overnight courier or certified or registered mail, return receipt requested, directed to such party at its
or his address set forth below (and service so made shall be deemed “personal service”) or by personal service or in
such other manner as may be permissible under the rules of said courts. THE COMPANY AND THE HOLDER EACH HEREBY WAIVES ANY RIGHT
TO A JURY TRIAL IN CONNECTION WITH ANY LITIGATION PURSUANT TO THIS AGREEMENT.

 

    	16 

     

    

 

Section 7. Indemnification
of Holder. Subject to the provisions of this Section 7, the Company will indemnify and hold each Holder and its directors,
officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a
Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Holder (within
the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles
notwithstanding a lack of such title or any other title) of such controlling persons (each, a “Holder Party”) harmless
from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments,
amounts paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation that any such Holder Party
may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements
made by the Company in this Agreement or in the other document related to this exchange or (b) any action instituted against Holder
Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate
of such Holder Party, with respect to any of the transactions contemplated by this exchange (unless such action is based upon a
breach of such Holder Party’s representations, warranties or covenants under the exchange or any agreements or understandings
such Holder Party may have with any such stockholder or any violations by such Holder Party of state or federal securities laws
or any conduct by such Holder Party which constitutes fraud, gross negligence, willful misconduct or malfeasance). If any action
shall be brought against any Holder Party in respect of which indemnity may be sought pursuant to this Agreement, such Holder Party
shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of
its own choosing reasonably acceptable to the Holder Party. Any Holder Party shall have the right to employ separate counsel in
any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such
Holder Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing, (ii)
the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there
is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the
position of such Holder Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than
one such separate counsel. The Company will not be liable to any Holder Party under this Agreement (y) for any settlement by a
Holder Party effected without the Company’s prior written consent, which shall not be unreasonably withheld or delayed; or
(z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Holder Party’s breach
of its representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Holder
Party may have with any such stockholder or any violations by such Holder Party of state or federal securities laws or any conduct
by such Holder Party which constitutes fraud, gross negligence, willful misconduct or malfeasance. The indemnification required
by this Section 7 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as
and when bills are received or are incurred however, each Holder Party who receives such interim payment agrees to reimburse the
Company for any such payment made by the Company to such Holder Party if it is finally determined in such action or proceeding
that such Holder Party is not entitled to indemnification pursuant to this Section 7. The indemnity agreements contained herein
shall be in addition to any cause of action or similar right of any Holder Party against the Company or others and any liabilities
the Company may be subject to pursuant to law.

 

    	17 

     

    

 

Section 8. Fees
and Expenses.   Except as expressly set forth below, each party shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of this Agreement. At each Closing, the Company shall pay the Holder
$2,500 for its legal fees. The Company shall pay all transfer agent fees (including,
without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any conversion
or exercise notice delivered by the Holder), stamp taxes and other taxes and duties levied in connection with the delivery of any
Exchange Securities to the Holder.

 

Section 9. Certain
Transactions. The Holder covenants that neither it, nor any affiliate acting on its behalf
or pursuant to any understanding with it will execute any “short sales” as defined in Rule 200 of Regulation SHO under
the Exchange Act of any of the Company’s securities during the period commencing with the execution of this Agreement and
ending on the later of (i) the Maturity Date (as defined in the Exchange Securities) or (ii) the date that the Exchange Securities
are no longer outstanding (provided that this provision shall not prohibit any sales made where a corresponding Notice of Conversion
(as defined in the Exchange Securities) is tendered to the Company and the shares received upon such conversion or exercise are
used to close out such sale). 

 

Section 10. Certificates.
Certificates evidencing the Underlying Shares shall not contain any legend: (i) while a registration
statement covering the resale of such security is effective under the Securities Act; (ii) following any sale of such Underlying
Shares pursuant to Rule 144; or (iii) if such legend is not required under applicable requirements of the Securities Act (including
judicial interpretations and pronouncements issued by the staff of the Commission). The Company shall cause its counsel
to issue a legal opinion to the Transfer Agent promptly after any of the events described in (i)-(iii) in the preceding sentence
if required by the Transfer Agent to effect the removal of the legend hereunder (with a copy to the Holder
and its broker). If all or any portion of an Exchange Security is converted at a time when
there is an effective registration statement to cover the resale of the Underlying Shares, or if such Underlying Shares may be
sold under Rule 144 or if such legend is not otherwise required under applicable requirements of the Securities Act (including
judicial interpretations and pronouncements issued by the staff of the Commission) then such Underlying Shares shall be issued
free of all legends.  The Company agrees that following the Effective Date or at such time as such legend is no longer
required under this Section, it will, no later than two Trading Days following the delivery by the Holder to the Company or the
Transfer Agent of a certificate representing Underlying Shares, as applicable, issued with a restrictive legend, deliver or cause
to be delivered to the Holder a certificate representing such shares that is free from all restrictive and other legends.  The
Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer
set forth in this Section.  Certificates for Underlying Shares subject to legend removal hereunder shall be transmitted
by the Transfer Agent to the Holder by crediting the account of the Holder’s prime broker with the Depository Trust Company
System as directed by the Holder.

 

    	18 

     

    

 

Section 11. Right
of First Refusal.

 

11.1  
From the date hereof until the date that is the 12-month anniversary of the last Closing, upon any issuance by the Company
of Common Stock, Common Stock Equivalents or debt for cash consideration, indebtedness or a combination of units thereof (a “Subsequent
Financing”), the Holder shall have the right to participate in up to an amount
of the Subsequent Financing equal to 100% of the Subsequent Financing on the same terms, conditions and price provided for in the
Subsequent Financing.

 

11.2  At
least four (4) Trading Days prior to the closing of the Subsequent Financing, the Company shall deliver to the Holder
a written notice of its intention to effect a Subsequent Financing (“Pre-Notice”), which Pre-Notice shall ask the Holder
if it wants to review the details of such financing (such additional notice, a “Subsequent Financing Notice”). Upon
the request of the Holder, and only upon a request by the Holder,
for a Subsequent Financing Notice, the Company shall promptly, but no later than one (1) Trading Day after such request, deliver
a Subsequent Financing Notice to the Holder. The Subsequent Financing Notice shall
describe in reasonable detail the proposed terms of such Subsequent Financing, the amount of proceeds intended to be raised thereunder
and the Person or Persons through or with whom such Subsequent Financing is proposed to be effected and shall include a term sheet
or similar document relating thereto as an attachment.

 

11.3  If
the Holder desires to participate in such Subsequent Financing, the Holder
must provide written notice to the Company that the Holder is willing to participate
in the Subsequent Financing, the amount of the Holder’s participation, and representing
and warranting that the Holder has such funds ready, willing, and available for investment
on the terms set forth in the Subsequent Financing Notice.

 

11.4  
If notifications by the Holder of its willingness to participate in the Subsequent
Financing (or to cause their designees to participate) is, in the aggregate, less than the total amount of the Subsequent Financing,
then the Company may effect the remaining portion of such Subsequent Financing on the terms and with the Persons set forth in the
Subsequent Financing Notice.

 

11.5  
The Company must provide the Holder with a second Subsequent Financing Notice,
and the Holder will again have the right of participation set forth above in this
Section, if the Subsequent Financing subject to the initial Subsequent Financing Notice is not consummated for any reason on the
terms set forth in such Subsequent Financing Notice within thirty (30) Trading Days after the date of the initial Subsequent Financing
Notice.

 

    	19 

     

    

 

11.6
  The Company and the Holder agree
that if the Holder elects to participate in the Subsequent Financing, the transaction
documents related to the Subsequent Financing shall not include any term or provision whereby the Holder
shall be required to agree to any restrictions on trading as to any of the Securities purchased hereunder or be required
to consent to any amendment to or termination of, or grant any waiver, release or the like under or in connection with, this Agreement,
without the prior written consent of the Holder.

 

11.7
  Notwithstanding anything to the contrary in this Section and unless otherwise
agreed to by the Holder, the Company shall either confirm in writing to the Holder
that the transaction with respect to the Subsequent Financing has been abandoned or shall publicly disclose its intention
to issue the securities in the Subsequent Financing, in either case in such a manner such that the Holder
will not be in possession of any material, non-public information, by the tenth (10th) Trading Day following
delivery of the Subsequent Financing Notice. If by such tenth (10th) Trading Day, no public disclosure regarding a
transaction with respect to the Subsequent Financing has been made, and no notice regarding the abandonment of such transaction
has been received by the Holder, such transaction shall be deemed to have been abandoned
and the Holder shall not be deemed to be in possession of any material, non-public
information with respect to the Company or any of its subsidiaries. 

 

11.8  
Notwithstanding the foregoing, this Section shall not apply in respect of an Exempt Issuance. “Exempt
Issuance” means the issuance of (i) securities issued under the Company’s equity incentive plan existing on
the date of this Agreement and any amendments thereto approved by the Board of Directors, including securities issuable upon conversion
or exercise of such securities, (ii) securities issued for consideration other than cash pursuant to a strategic arrangement, joint
venture, merger, consolidation, acquisition, or similar business combination approved by the Board of Directors and (iii) securities
issued upon the exercise or exchange of or conversion of any Exchange Securities issued hereunder and/or other securities exercisable
or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that
such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease
the exercise price, exchange price or conversion price of such securities.

 

Section 12. Counterparts.
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile
signature shall be considered due execution and shall be binding upon the signatory thereto with the same force and effect as if
the signature were an original, not a facsimile signature.

 

Section 13. Headings.
The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, this
Agreement.

 

    	20 

     

    

 

Section 14. Severability.
If any provision of this Agreement shall be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall
not affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability
of any provision of this Agreement in any other jurisdiction.

 

Section 15. Entire
Agreement; Amendments. This Agreement supersedes all other prior oral or written agreements between the Holder, the Company,
their affiliates and persons acting on their behalf with respect to the matters discussed herein, and this Agreement and the instruments
referenced herein contain the entire understanding of the parties with respect to the matters covered herein and therein and, except
as specifically set forth herein or therein, neither the Company nor the Holder makes any representation, warranty, covenant or
undertaking with respect to such matters. No provision of this Agreement may be amended other than by an instrument in writing
signed by the Company and the Holder. No provision hereof may be waived other than by an instrument in writing signed by the party
against whom enforcement is sought.

 

Section 16. Notices.
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must
be in writing and will be deemed to have been delivered: (a) upon receipt, when delivered personally; (b) upon receipt, when sent
by facsimile (provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending
party); or (c) one calendar day (excluding Saturdays, Sundays, and national banking holidays) after deposit with an overnight courier
service, in each case properly addressed to the party to receive the same.

 

The addresses and facsimile numbers for
such communications shall be:

 

If to the Company:

 

MyECheck, Inc.

2600 E. Bidwell Street #190

Folsom, CA 95630

Attn: CEO

 

If to the Holder:

 

Redwood Management, LLC

16850 Collins Avenue, Suite 112-341

Sunny Isles, FL 33160

Attn: Gary Rogers

 

With a copy (which shall not constitute notice) to:

 

Robinson Brog Leinwand Greene Genovese & Gluck P.C.

875 Third Avenue, 9th Floor

New York, NY 10022

Attn: David E. Danovitch, Esq.

 

    	21 

     

    

 

or to such other address and/or facsimile
number and/or to the attention of such other person as the recipient party has specified by written notice given to each other
party five (5) days prior to the effectiveness of such change.

 

Section 17. Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and
assigns, including any purchasers of the Exchange Securities. The Holder may assign some or all of their rights hereunder without
the consent of the Company, in which event such assignee shall be deemed to be the Holder hereunder with respect to such assigned
rights.

 

Section 18. No Third
Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted successors
and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person.

 

Section 19. Survival
of Representations. The representations and warranties of the Company and the Holder contained in Sections 2 and 3, respectively,
will survive the closing of the transactions contemplated by this Agreement.

 

Section 20. Further
Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall
execute and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.

 

[Signature Page Follows]

 

    	22 

     

    

  

IN WITNESS WHEREOF, the parties have executed
this Exchange Agreement as of the date first written above.

 

	MyECheck, Inc.	 
	 	 
	By:	/s/  Ed Starrs	 	 
	Name:	ED STARRS	 	 
	Title:	CEO	 	 
	 	 
	REDWOOD MANAGEMENT, LLC	 
	 	 
	By:	 	 	 
	Name:	 	 	 
	Title:	 	 	 

 

     

     

    

 

IN WITNESS WHEREOF, the parties have executed
this Exchange Agreement as of the date first written above.

  

	MyECheck, Inc.	 
	 	 
	By:	 	 	 
	Name:	 	 	 
	Title:	 	 	 
	 	 
	REDWOOD MANAGEMENT, LLC	 
	 	 
	By:	/s/ John DeNobile	 	 
	Name:	John DeNobile	 	 
	Title:	Manager	 	 

  

     

     

    

 

SCHEDULE
1

 

	Closing	 	Amount of Securities	 	 	Closing
                                         Date 

	1	 	$	50,000	 	 	On the Effective Date 

	2	 	$	200,000	 	 	90 days after Company becomes a full reporting Company with the SEC
	3	 	$	200,000	 	 	120 days after Company becomes a full reporting Company with the SEC
	4	 	$	250,000	 	 	150 days after Company becomes a full reporting Company with the SEC

 

     

     

    

 

Exhibit
A

 

     

     

    

 

Exhibit
B

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00249-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00249-of-00352.parquet"}]]